Literature DB >> 19270709

A new role of substance P as an injury-inducible messenger for mobilization of CD29(+) stromal-like cells.

Hyun Sook Hong1, Jungsun Lee, EunAh Lee, Young Sam Kwon, Eunkyung Lee, Woosung Ahn, Mei Hua Jiang, Jae Chan Kim, Youngsook Son.   

Abstract

Tissue injury may create a specific microenvironment for inducing the systemic participation of stromal-like cells in the repair process. Here we show that substance P is an injury-inducible factor that acts early in the wound healing process to induce CD29(+) stromal-like cell mobilization. Likewise, mobilization of such cells also occurs in uninjured mice, rats and rabbits if substance P is intravenously injected. Upon further characterization these substance P-mobilized CD29(+) cells were found to be similar to stromal cells from a number of connective tissues, including bone marrow (that is, bone marrow stromal cells, or BMSCs). Both substance P injection and transfusion of autologously derived substance P-mobilized CD29(+) cells from uninjured rabbits accelerated wound healing in an alkali burn model. Also, epithelial engraftment of the transfused cells into the injured tissue occurred during the wound healing. Finally, using human BMSCs as a test population, we show that substance P stimulates transmigration, cell proliferation, activation of the extracellular signal-related kinases (Erk) 1 and 2 and nuclear translocation of beta-catenin in vitro. This finding highlights a previously undescribed function of substance P as a systemically acting messenger of injury and a mobilizer of CD29(+) stromal-like cells to participate in wound healing.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19270709     DOI: 10.1038/nm.1909

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  46 in total

1.  Fibroblast differentiation of bone marrow-derived cells during wound repair.

Authors:  Susan R Opalenik; Jeffrey M Davidson
Journal:  FASEB J       Date:  2005-07-12       Impact factor: 5.191

Review 2.  Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views.

Authors:  Donald G Phinney; Darwin J Prockop
Journal:  Stem Cells       Date:  2007-09-27       Impact factor: 6.277

3.  Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion.

Authors:  Yasushi Sato; Hironobu Araki; Junji Kato; Kiminori Nakamura; Yutaka Kawano; Masayoshi Kobune; Tsutomu Sato; Koji Miyanishi; Tetsuji Takayama; Minoru Takahashi; Rishu Takimoto; Satoshi Iyama; Takuya Matsunaga; Seiji Ohtani; Akihiro Matsuura; Hirofumi Hamada; Yoshiro Niitsu
Journal:  Blood       Date:  2005-04-07       Impact factor: 22.113

4.  Multipotential mesenchymal stem cells are mobilized into peripheral blood by hypoxia.

Authors:  Gaël Y Rochefort; Bruno Delorme; Adriana Lopez; Olivier Hérault; Pierre Bonnet; Pierre Charbord; Véronique Eder; Jorge Domenech
Journal:  Stem Cells       Date:  2006-06-15       Impact factor: 6.277

5.  Bone marrow-derived mesenchymal stem cells in repair of the injured lung.

Authors:  Mauricio Rojas; Jianguo Xu; Charles R Woods; Ana L Mora; Willy Spears; Jesse Roman; Kenneth L Brigham
Journal:  Am J Respir Cell Mol Biol       Date:  2005-05-12       Impact factor: 6.914

Review 6.  Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells.

Authors:  Tsvee Lapidot; Isabelle Petit
Journal:  Exp Hematol       Date:  2002-09       Impact factor: 3.084

7.  Substance P-induced activation of p42/44 mitogen-activated protein kinase associated with cell proliferation in human tracheal smooth muscle cells.

Authors:  Chuen-Mao Yang; Li-Der Hsiao; Chin-Sung Chien; Chih-Chung Lin; Shu-Fen Luo; Chuan-Chwan Wang
Journal:  Cell Signal       Date:  2002-11       Impact factor: 4.315

8.  Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1.

Authors:  Daniel J Ceradini; Anita R Kulkarni; Matthew J Callaghan; Oren M Tepper; Nicholas Bastidas; Mark E Kleinman; Jennifer M Capla; Robert D Galiano; Jamie P Levine; Geoffrey C Gurtner
Journal:  Nat Med       Date:  2004-07-04       Impact factor: 53.440

9.  Endogenous substance P in corneal epithelial cells and keratocytes.

Authors:  Michifumi Watanabe; Kiyo Nakayasu; Minoru Iwatsu; Atsushi Kanai
Journal:  Jpn J Ophthalmol       Date:  2002 Nov-Dec       Impact factor: 2.447

10.  Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects.

Authors:  Luis A Ortiz; Frederica Gambelli; Christine McBride; Dina Gaupp; Melody Baddoo; Naftali Kaminski; Donald G Phinney
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-18       Impact factor: 12.779

View more
  113 in total

1.  Substance P affects growth factors in Pseudomonas aeruginosa-infected mouse cornea.

Authors:  Megan E B Foldenauer; Sharon A McClellan; Ronald P Barrett; Yunfan Zhang; Linda D Hazlett
Journal:  Cornea       Date:  2012-10       Impact factor: 2.651

2.  Substance P promotes wound healing in diabetes by modulating inflammation and macrophage phenotype.

Authors:  Ermelindo C Leal; Eugénia Carvalho; Ana Tellechea; Antonios Kafanas; Francesco Tecilazich; Cathal Kearney; Sarada Kuchibhotla; Michael E Auster; Efi Kokkotou; David J Mooney; Frank W LoGerfo; Leena Pradhan-Nabzdyk; Aristidis Veves
Journal:  Am J Pathol       Date:  2015-04-11       Impact factor: 4.307

3.  Immunohistological localization of endogenous unlabeled stem cells in wounded skin.

Authors:  Song Hong; Bhagwat V Alapure; Yan Lu; Haibin Tian; Quansheng Wang
Journal:  J Histochem Cytochem       Date:  2014-01-07       Impact factor: 2.479

Review 4.  Mesenchymal stem cells: paracrine signaling and differentiation during cutaneous wound repair.

Authors:  Anne M Hocking; Nicole S Gibran
Journal:  Exp Cell Res       Date:  2010-05-13       Impact factor: 3.905

Review 5.  Transamniotic Stem Cell Therapy.

Authors:  Stefanie P Lazow; Dario O Fauza
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

6.  Pharmacological tools to mobilise mesenchymal stromal cells into the blood promote bone formation after surgery.

Authors:  Tariq G Fellous; Andia N Redpath; Mackenzie M Fleischer; Sapan Gandhi; Samantha E Hartner; Michael D Newton; Moïra François; Suet-Ping Wong; Kate H C Gowers; Adam M Fahs; Daniel R Possley; Dominique Bonnet; Paula Urquhart; Anna Nicolaou; Kevin C Baker; Sara M Rankin
Journal:  NPJ Regen Med       Date:  2020-02-21

7.  Current approaches and future directions in the management of pterygium.

Authors:  Kyoung Woo Kim; Jae Chan Kim
Journal:  Int J Ophthalmol       Date:  2018-05-18       Impact factor: 1.779

Review 8.  Targeting Type 1 Diabetes: Selective Approaches for New Therapies.

Authors:  Daniel F Sheehy; Sean P Quinnell; Arturo J Vegas
Journal:  Biochemistry       Date:  2019-01-17       Impact factor: 3.162

9.  Neuropeptide Y regulates the hematopoietic stem cell microenvironment and prevents nerve injury in the bone marrow.

Authors:  Min Hee Park; Hee Kyung Jin; Woo-Kie Min; Won Woo Lee; Jeong Eun Lee; Haruhiko Akiyama; Herbert Herzog; Grigori N Enikolopov; Edward H Schuchman; Jae-sung Bae
Journal:  EMBO J       Date:  2015-04-27       Impact factor: 11.598

Review 10.  In Vitro Innovation of Tendon Tissue Engineering Strategies.

Authors:  Maria Rita Citeroni; Maria Camilla Ciardulli; Valentina Russo; Giovanna Della Porta; Annunziata Mauro; Mohammad El Khatib; Miriam Di Mattia; Devis Galesso; Carlo Barbera; Nicholas R Forsyth; Nicola Maffulli; Barbara Barboni
Journal:  Int J Mol Sci       Date:  2020-09-14       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.